HuagongsheHuagongshe Chemistry Print Report · For research reference only
1-Boc-4-(3-hydroxypropyl)piperazine → HCID 67019221, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 1-Boc-4-(3-hydroxypropyl)piperazine | HCID 16217800 | — |
| Reactant | 4-((4-Fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-ol | HCID 135530832 | — |
| Product | HCID 67019221 | HCID 67019221 | 70% |
Reaction Steps
Using an analogous procedure to that described for the preparation of the starting material in Example 11, 1-tert-butoxycarbonyl-4-(3-hydroxypropyl)piperazine (432 mg, 1.77 mmol) was reacted with 4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-7-hydroxy-6-methoxyquinazoline (500 mg, 1.47 mmol), (prepared as described for the starting material in Example 7). The product was purified by column chromatography, eluting with 2%-5% methanol/methylene chloride to give tert-butyl 4-[3-(4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxyquinazoline-7-yloxy)propyl]piperazine-1-carboxylate (582 mg, 70%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US07268230B2 |
| Source dataset | uspto-grants-2007_09 |
| ORD ID | ord-28f060e4b960491eb9c7601138f22db6 |
| Source note | uspto-grants-2007_09 |